We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+7.22%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
AUM
$9.67B
AUM Growth
+$2.26B
Cap. Flow
+$1.95B
Cap. Flow %
20.18%
Top 10 Hldgs %
21.78%
Holding
2,843
New
810
Increased
656
Reduced
567
Closed
731

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$257M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$254M
3
MSFT icon
Microsoft
MSFT
+$247M
4
AER icon
AerCap
AER
+$77.8M
5
ON icon
ON Semiconductor
ON
+$61.6M

Sector Composition

Rank Sector Weight
1 Technology 15.23%
2 Consumer Discretionary 11.75%
3 Industrials 11.23%
4 Financials 8.63%
5 Healthcare 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NAT icon
2451
Nordic American Tanker
NAT
$1.48B
-11,898
Closed -$30K
NAUT icon
2452
Nautilus Biotechnolgy
NAUT
$121M
-13,438
Closed -$83K
NAVI icon
2453
Navient
NAVI
$886M
-16,902
Closed -$333K
NBR icon
2454
Nabors Industries
NBR
$1.37B
-26,602
Closed -$2.57M
NEOG icon
2455
Neogen
NEOG
$2.61B
-36,466
Closed -$1.58M
NERV icon
2456
Minerva Neurosciences
NERV
$231M
-4,899
Closed -$68K
NFG icon
2457
National Fuel Gas
NFG
$7.84B
-7,337
Closed -$385K
NG icon
2458
NovaGold Resources
NG
$3.83B
-23,930
Closed -$165K
NGNE icon
2459
Neurogene
NGNE
$773M
-570
Closed -$82K
NHC icon
2460
National Healthcare
NHC
$3.66B
-13,560
Closed -$949K
NIC icon
2461
Nicolet Bankshares
NIC
$3.63B
-6,260
Closed -$464K
NJR icon
2462
New Jersey Resources
NJR
$5.43B
-24,314
Closed -$846K
NLY icon
2463
Annaly Capital Management
NLY
$17.5B
-72,463
Closed -$2.44M
NMG
2464
Nouveau Monde Graphite
NMG
$494M
-14,142
Closed -$79K
NNOX icon
2465
Nano X Imaging
NNOX
$67.6M
-9,575
Closed -$215K
NPK icon
2466
National Presto Industries
NPK
$1.07B
-3,252
Closed -$267K
NRC icon
2467
NRC Health Common Stock
NRC
$491M
-11,489
Closed -$484K
NRIX icon
2468
Nurix Therapeutics
NRIX
$2.77B
-10,747
Closed -$322K
NTCT icon
2469
NETSCOUT
NTCT
$2.8B
-168,732
Closed -$4.55M
NTLA icon
2470
Intellia Therapeutics
NTLA
$1.8B
-3,467
Closed -$465K
NVEE
2471
DELISTED
NV5 Global
NVEE
-74,216
Closed -$1.83M
NVRI icon
2472
Enviri
NVRI
$582M
-28,764
Closed -$488K
NVST icon
2473
Envista
NVST
$4.37B
-6,947
Closed -$290K
OCFT
2474
DELISTED
OneConnect Financial Technology
OCFT
-2,580
Closed -$106K
OCSL icon
2475
Oaktree Specialty Lending
OCSL
$1.14B
-15,487
Closed -$328K

Similar funds

Michael Gelband's Q4 2021 Portfolio in Review

As of Q4 2021, Michael Gelband held 2,843 positions worth $9.67B, up 30% from $7.41B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Michael Gelband deployed $1.95B of net new capital in Q4 2021, opening 810 new positions and adding to 656 existing holdings. Its largest new stake was Amazon: 1,500,500 shares worth $250M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Advanced Micro Devices, an estimated $76.2M trimmed.

  • Michael Gelband's largest Q4 2021 buy was Amazon: 1,500,500 shares worth $250M.
  • Michael Gelband added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $254M increase.
  • Michael Gelband's biggest Q4 2021 reduction was Advanced Micro Devices, cutting an estimated $76.2M.
  • Michael Gelband fully exited Diamondback Energy in Q4 2021, selling an estimated $44.8M.
  • Michael Gelband's ten largest holdings make up 22% of its $9.67B portfolio in Q4 2021.
  • Michael Gelband opened 810 new positions and closed 731 in Q4 2021.
  • Michael Gelband's portfolio value rose 30% quarter-over-quarter to $9.67B.

Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.